Bon Natural Life Ltd SEC filings BON
Bon Natural Life Ltd has 152 filings in SEC EDGAR's recent list, going back to Jul 13, 2020. Its latest annual report, Form 20-F, was filed on Jan 23, 2026 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Sep 23, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | May 15, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 23, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| 3 | Initial insider ownership | Apr 10, 2026 | Apr 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 21, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 17, 2025 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- BON (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Shaanxi, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1816815
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.